• No results found

First-line therapy in HER2 positive metastatic breast cancer: is the mosaic fully completed or are we missing additional pieces?

N/A
N/A
Protected

Academic year: 2020

Share "First-line therapy in HER2 positive metastatic breast cancer: is the mosaic fully completed or are we missing additional pieces?"

Copied!
11
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Table 1 Studies with anti-HER2 molcules plus hormonal therapy in the first-line metastaic breast cancer
Table 3 Ongoing clinical trials evaluating new anti-HER2 molecules combined with hormone therapy in first-line setting

References

Related documents

When you need to alleviate the load on your service desk and still manage to keep your customers happy - establishing seamless self service processes in your service desk is

As there is no sufficient data available on their use in the population of eastern India [9], the pres- ent study was carried out to analyze the patterns of

An analysis of individual answers suggested the following categories of replies. which cover the majority of replies:.. This category includes students who never

In particular, assume 2 n 0.5+ε -hard constant-noise LPN or 2 n 0.25+ε - hard low-noise LPN, we obtain a collision resistant hash function that evaluates in parallel only a single

Investigation of nonlinear e ff ects in the strong field QED (e ff ectiveness of the electron- positron plasma (EPP) production from vacuum in di ff erent models of the

The purpose of this in vivo study was to compare the accuracy of Propex II and iPex II electronic apex locator (EAL) in determining the WL under clinical conditions, to that

Recent work has shown that zyxin also shuttles through the nucleus – most likely by association with other LIM proteins – and may regulate gene transcription [27 – 29]. During

or spoken language, especially when it is studied in order to understand how people use language ” this point means. how it’s important to develop discourse